Artelo Biosciences, Inc. (ARTL) vs Eiger BioPharmaceuticals, Inc. (EIGRQ)
Artelo Biosciences, Inc. and Eiger BioPharmaceuticals, Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and Eiger BioPharmaceuticals, Inc. are of similar size ($2.7M and $2.6M). Artelo Biosciences, Inc. has the higher net margin (0.00% vs −475.3%) and the higher return on invested capital (−865.9% vs −3,674.6%). Across the 13 metrics below, Eiger BioPharmaceuticals, Inc. leads on 7 and Artelo Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | ARTL | EIGRQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 99.85% | 65.16% |
| Operating margin | 0.00% | (455.12%) | 0.00% |
| Net margin | 0.00% | (475.26%) | 0.00% |
| Free cash flow margin | 0.00% | (474.11%) | 0.00% |
| Return on equity | (705.71%) | (367.00%) | (57.72%) |
| Return on assets | (234.30%) | (94.31%) | (49.22%) |
| Return on invested capital | (865.85%) | (3,674.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack